Chenguang Wu
Jingjing Wang1
Hailing Zhao
Xin Li
Lifan Wang
Peng Liu
Ping Li- 1Renal Division, Heilongjiang Academy of Chinese Medicine Sciences, Harbin, China
- 2China-Japan Friendship Hospital, Beijing, China
- 3Shunyi Hospital, Beijing Hospital of Traditional Chinese Medicine, Beijing, China
Diabetic nephropathy (DN) is a kidney disorder secondary to diabetes and is one of the main diabetic microvascular complications. As the number of diabetic patients grows, DN has become the leading cause of chronic kidney disease in China. Unfortunately, no definitive cure currently exists for DN. Cornus officinalis (CO), frequently utilized in clinical settings for diabetes mellitus treatment, has proven vital in both preventing and treating DN. This article explores the pathogenesis of DN and how CO and its active compounds regulate glucose and lipid metabolism, exhibit anti-inflammatory properties, inhibit oxidative stress, regulate podocytes, and manage autophagy. The mechanism and role of and its active compounds in the treatment of DN are discussed.
Introduction
Diabetic nephropathy (DN) is one of the most common and severe complications of diabetes mellitus (DM). Associated with heightened morbidity and mortality rates among DM patients, DN is a principal cause of end-stage renal failure worldwide (Samsu, 2021). As the global prevalence of diabetes surges (Xue et al., 2017), the incidence of DN will concurrently rise unless timely and effective clinical strategies for its prevention are implemented (Gheith et al., 2016). Nowadays, Chinese herbal medicine, with its unique advantages, plays a core role in DN.
Cornus officinalis (CO) is a valuable Chinese herbal medicine (Gao et al., 2021). Modern pharmacology shows that CO has various effects such as lowering blood glucose, anti-inflammatory, antioxidant, and anti-apoptotic properties (Lou et al., 2021); and its main components, iridoid glycosides and polyphenols can significantly improve the metabolic parameters of DN (Yamabe et al., 2007a). CO effectively ameliorated insulin resistance, lowered blood glucose, and alleviated symptoms of DN patients (Park et al., 2013). Here, we illustrate the mechanism of CO and its active compounds to improve DN in Table 1 and Figure 1.
TABLE 1. The role of active compounds of Cornus officinalis against DN.
FIGURE 1. The mechanism of Cornus Officinalis and its active compounds in DN.
Cornus officinalis in DN
The mechanisms of CO in treating DN mainly include regulating glucose and lipid metabolism, anti-oxidative stress, anti-inflammatory, protecting podocytes, and regulating autophagy.
Regulating glucose metabolism
Controlling blood glucose is considered an effective treatment for DN (Chatterjee et al., 2017). CO primarily lowers blood glucose through two primary pathways.
Increasing insulin secretion
CO total triterpenoids have no significant effect on normal mice’s blood glucose levels, but can significantly reduce the blood glucose levels of alloxan diabetic model mice, increase serum insulin levels (Han et al., 2006). The total saponins of CO can lower the blood glucose and insulin levels of streptozotocin (STZ)-induced diabetic rats (Liu et al., 2012). CO has been demonstrated to exert a protective effect on pancreatic β-cells, enhancing pancreatic pathological recovery, increasing the number of insulin-releasing β-cells, and augmenting glucose-stimulated insulin secretion (Han et al., 2014). CO extract upregulated the expression of nuclear factor of activated T-cells 2, inhibited cytokine-mediated β-cell death, improved β-cell function (Sharp-Tawfik et al., 2019). Additionally, the methanol extract of CO can reduce the expression of hepatic gluconeogenesis genes, shield pancreatic B cells from damage, and boost insulin secretion (Wu, 2012). The alcohol extraction of CO cyclic enol ether triterpenoid glycosides and administered the alcohol extract to diabetic rat models by gavage (Qian et al., 2001).
Enhancing insulin sensitivity and mitigating insulin resistance
CO total iridoid glycosides can effectively reduce insulin levels in mice, thus reducing blood lipids and improving insulin resistance (Liu et al., 2016).These iridoid glycosides notably improved insulin resistance in DM mice and decreased the expression levels of p-ERK1/2, p-P65, p-P38, and p-JNK1/2 proteins in liver tissues (Kitada et al., 2016). Loganin and Morroniside in CO had significant effects in improving insulin resistance in mice and promoting glucose consumption in liver cells (Huang et al., 2017). PPARG is the first gene abnormally expressed due to induced insulin resistance, playing a crucial role in insulin signaling regulation and insulin sensitivity (Malodobra-Mazur et al., 2021). CO fruit can significantly increase PPARG expression in cells, reversing insulin resistance, enhancing glucose uptake after insulin stimulation (Malodobra-Mazur et al., 2022).
Furthermore, the raw iridoid glycoside extract from CO effectively alleviated hyperglycemia symptoms and reduced the accumulation of advanced glycation end products in the kidneys (Yamabe et al., 2007b). CO total triterpenoids had a more apparent effect in inhibiting glucose absorption and promoting glucose utilization, exerting a hypoglycemic effect (Fan et al., 2017). CO polysaccharide can significantly enhance glucose uptake and consumption in IR-HepG2 cells, reduce glycated hemoglobin HbA1c levels and amylase activity, lower fasting blood glucose, and reduce body weight (Fu et al., 2021). CO extract diminishes glucose absorption by inhibiting α-glucosidase activity in intestinal villus epithelial cells. Conversely, it enhances glucose uptake and utilization by promoting insulin secretion and increasing insulin sensitivity in peripheral tissues, while also inhibiting gluconeogenesis (Gao et al., 2021).
Regulating lipid metabolism
Lipid peroxidation is a significant contributor to the damage of blood cell structures in diabetic patients. Studies have shown that CO fruit extract can raise the levels of GSH and MCH in diabetic rats, and the antioxidants, iridoid glycosides. The polyphenols in the extract can neutralize active oxygen forms and inhibit lipid peroxidation, thus providing antioxidative protection (Dzydzan et al., 2019). CO extract can also lower blood lipid levels in STZ-induced diabetic rats (Gao et al., 2020).
Improving oxidative stress
Oxidative stress is a state in which tissue damage occurs due to an imbalance between oxidants and antioxidants (Kao et al., 2010). CO extract has significant antioxidative activity and increases the activity of antioxidative enzymes, with strong scavenging abilities for ABTS free radicals (Hwang et al., 2016). CO can reduce the kidney weight ratio, downregulate plasma creatinine, urea nitrogen, and uric acid levels, modulate the BMP-7 and TGF-β1/Smad signaling pathway, downregulate ROS, MCP-1, NF-κB expression (Li et al., 2015). Loganin can lower reactive oxygen levels, improve leukocyte antioxidative status, boost activities of glutathione reductase, glutathione peroxidase, and catalase, thereby increasing GSH levels in leukocytes (Liu et al., 2012). Despite total triterpenic acid from CO not significantly impacting blood glucose levels in diabetic rats, it can reduce urinary protein, Scr, and BUN levels and improve renal pathological changes. Total triterpenic acid can decrease MDA levels and augment superoxide dismutase, catalase, and glutathione peroxidase activities, reducing the expression of TGF-β1 in the kidney tissue of diabetic rats (Qi et al., 2014).
Anti-inflammatory
Immune and inflammatory responses play an important role in the pathogenesis of DN (Tavafi, 2013). Numerous studies suggest that IL-1β, IL-6, and IL-18 are major contributors to the progression of diabetic nephropathy (Wong et al., 2007). Experimental findings reveal that CO extract can disrupt LPS-induced macrophages and reduce the expression of IL-1β, IL-6, and NF-κB. Its renoprotective effect may be realized by downregulating AKT phosphorylation (Najjar et al., 2021). Loganin significantly inhibit macrophage infiltration, and counter inflammation, suggesting that Loganin’s therapeutic effect on DN may be related to inhibiting macrophage infiltration, activating the MCP-1/CCR2 signaling pathway, and suppressing inflammatory cytokines (Du et al., 2021). CO cyclic ether terpene glycosides significantly inhibit the secretion levels of AGEs-induced inflammatory factors, and dose-dependently alleviate the AGEs-induced inflammation in rat mesangial cells HBZY-1 (Guo et al., 2013).
Protected podocytes
Morroniside has a protective effect on podocyte apoptosis, and its mechanism may involve restoring blocked autophagy flux and inhibiting H2O2-induced NADPH oxidase 4 (NOX4) overexpression to prevent podocyte apoptosis (Gao et al., 2020). The optimal compatibility of components in CO has been shown to protect against early kidney disease in type 2 diabetic rats by increasing WT1 expression in glomerular podocytes (Liu et al., 2012). Loganin and morroniside may jointly inhibit the apoptosis of podocytes in DN by targeting AGEs RAGE and its downstream pathways p38 MAPK and Nox4 (Chen et al., 2020).
Regulating autophagy
The main clinical pathological changes in DN are glomerulosclerosis and renal tubulointerstitial fibrosis, with renal interstitial fibrosis characterized by renal parenchymal cell injury and massive extracellular matrix deposition (Guo et al., 2022). CO can promote a highly protective mechanism in pancreatic β-cells through autophagy and the Kelch-like ECH-associated protein 1 (Keap1)/nuclear factor erythroid 2-related factor 2 (Nrf2) pathway mediated by the p62 adapter molecule (Sharp-Tawfik et al., 2022). Morroniside can reduce oxidative stress-induced podocyte apoptosis by restoring impaired autophagic flux and inhibiting the overexpression of NOX4 (Gao et al., 2020).
Others
CO can improve kidney injury in DN rats and ultimately exert kidney-protective effects by blocking the activation of the Wnt/β-catenin signaling pathway and regulating the composition of gut microbiota (Ju et al., 2022). Treatment with CO significantly improved the intestinal microbiota composition and fecal metabolite characteristics in CKD rats, and CO can reverse the CKD condition (Zhang et al., 2021).
Traditional Chinese medicine prescription and clinical trials containing CO
Common traditional Chinese medicine prescriptions containing cornus officinalis for the clinical treatment of DKD include Shenqi Dihuang Decoction, Jinkui Shenqi Pill, and Liuwei Dihuang Pill. Experiments have shown that Shenqi Dihuang Decoction can intervene in the inflammatory response of early DN patients, reduce proteinuria, protect renal function, and improve the patient’s endothelial function and hemorheology, achieving normal recovery of microcirculation (Wang et al., 2018). Studies by Liu Chunyan and others found that Jinkui Shenqi Pill can downregulate the phosphorylation levels of JNK1 and Bcl-2, significantly reduce the fragments of activated caspase-3, and may protect podocytes and delay the progress of DKD through the JNK1/Bcl-2 pathway (Liu et al., 2019). Liuwei Dihuang decoction has been proven to alleviate early DN abnormalities mediated by the inhibition of the endothelin-1 reactive oxygen species (ET-ROS) system and increasing MMPs activity (He et al., 2007). In the study of medication rules, Cornus officinalis appears with a frequency of >30%. Its nourishing and kidney-replenishing effects can cope with the basic pathogenesis of both Qi and Yin deficiency in DN (Wen et al., 2015). In the clinical information system analysis summary of traditional Chinese medicine treatment of diabetic nephropathy medication rules by Yang Chaomao and others, Cornus officinalis was ranked in the top 5 in terms of usage frequency. There is a strong correlation between the three medicines Salvia miltiorrhiza, Cornus officinalis, and Astragalus. Combined use can strengthen the spleen, nourish the livers and kidneys, and replenish Qi, nourish blood and remove blood stasis (Yang et al., 2022).
Conclusion and perspectives
The pathogenesis of DN is complex, and there is less research on the role of CO in autophagy and the regulation of gut microbiota. More in-depth investigations should be conducted on additional mechanisms. Chinese herbal medicine has complex ingredients, and more effective components of CO can be explored. The therapeutic effect of CO in improving inflammation and oxidative stress of glomerular mesangial cells, podocytes and renal tubular epithelial cells in DN is gradually becoming clear. Moving forward, the treatment of DN with CO can be discussed from multiple angles, levels, and directions, with the aim of providing better treatment for patients.
Author contributions
LW, PL, PiL: conceptualization. CW, JW, RZ: writing-original draft preparation, editing, and revising. XL, PL, HZ, PiL: supervision. All authors contributed to the article and approved the submitted version.
Funding
This study was supported by the National Natural Science Foundation of China (Nos. 82274489, 82174144, 82174296, 82004328).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Chatterjee, S., Khunti, K., and Davies, M. J. (2017). Type 2 diabetes. Lancet 389 (10085), 2239–2251. doi:10.1016/S0140-6736(17)30058-2
Chen, Y. P., Chen, J., Jiang, M., Fu, Y. X., Zhu, Y. H., Ni, J., et al. (2020). Loganin and catalpol exert cooperative ameliorating effects on podocyte apoptosis upon diabetic nephropathy by targeting AGEs-RAGE signaling. Life Sci. 252, 117653. doi:10.1016/j.lfs.2020.117653
Du, Q., Fu, Y. X., Shu, A. M., Lv, X., Chen, Y. P., Gao, Y. Y., et al. (2021). Loganin alleviates macrophage infiltration and activation by inhibiting the MCP-1/CCR2 axis in diabetic nephropathy. Life Sci. 272, 118808. doi:10.1016/j.lfs.2020.118808
Dzydzan, O., Bila, I., Kucharska, A. Z., Brodyak, I., and Sybirna, N. (2019). Antidiabetic effects of extracts of red and yellow fruits of cornelian cherries (Cornus mas L) on rats with streptozotocin-induced diabetes mellitus. Food Funct. 10 (10), 6459–6472. doi:10.1039/c9fo00515c
Fan, S. S., Zhu, J. J., Xu, D. Q., Xie, Y. H., Wang, C. L., Wang, H., et al. (2017). Study on the hypoglycemic pathway of total terpenoids from Cornus officinalis. Chin. Pharmacol. Bull. 33 (07), 1014–1019. doi:10.3969/j.issn.1001-1978.2017.07.025
Fu, C. Y., Ren, L., Liu, W. J., Sui, Y., Nong, Q. N., Xiao, Q. H., et al. (2021). Structural characteristics of a hypoglycemic polysaccharide from Fructus Corni. Carbohydr. Res. 506, 108358. doi:10.1016/j.carres.2021.108358
Gao, X., Liu, Y., An, Z. C., and Ni, J. (2021). Active components and pharmacological effects of cornus officinalis: Literature review. Front. Pharmacol. 12 (12), 633447. doi:10.3389/fphar.2021.633447
Gao, X., Liu, Y., Wang, L., Sai, N., Liu, Y., and Ni, J. (2020). Morroniside inhibits H(2)O(2)-induced podocyte apoptosis by down-regulating NOX4 expression controlled by autophagy in vitro. Front. Pharmacol. 11, 533809. doi:10.3389/fphar.2020.533809
Gheith, O., Farouk, N., Nampoory, N., Halim, M. A., and Al-Otaibi, T. (2016). Diabetic kidney disease: World wide difference of prevalence and risk factors. J. Nephropharmacol 5 (1), 49–56.
Guo, J., Zhang, X. S., and Liu, J. P. (2013). Regulation of total iridoid glycosides of Cornus officinalis on renal mesangial inflammatory response induced by advanced glycation end products. Chin. Tradit. Pat. Med. 35 (10), 2067–2072. doi:10.3969/j.issn.1001-1528.2013.10.001
Guo, J. H., Wei, H., Liang, Z. Z., and He, G. B. (2022). Influencing factors of early diabetic nephropathy in patients with type 2 diabetes mellitus. Chin. J. Public Health Eng. 21 (01), 99–103. doi:10.19937/j.issn.1671-4199.2022.01.032
Han, J. C., Ji, H., Xue, C. F., Yin, M., and Lou, F. C. (2006). The hypoglycemic effect of total glycosides from Cornus officinalis. Chin. J. Nat. Med. 31 (2), 125–129.
Han, Y., Jung, H. W., and Park, Y. K. (2014). Selective therapeutic effect of cornus officinalis fruits on the damage of different organs in STZ-induced diabetic rats. Am. J. Chin. Med. 42 (5), 1169–1182. doi:10.1142/S0192415X14500736
He, H. B., Yang, X. Z., Zeng, X. W., Shi, M. Q., Yang, J., Wu, L. M., et al. (2007). Down-regulation of FKBP12.6 and SERCA2a contributes to acute heart failure in septic shock and is related to an up-regulated endothelin signalling pathway. J. Pharm. Pharmacol. 59 (9), 977–984. doi:10.1211/jpp.59.7.0010
Huang, M. H., Ge, C. J., and Yu, S. J. (2017). Effects of loganin and mononucleoside in Cornus officinalis on HepG2 cells and their insulin resistance model. Mod. Food Sci. Technol. 33 (04), 13–18. doi:10.13982/j.mfst.1673-9078.2017.4.003
Hwang, K. A., Hwang, Y. J., and Song, J. (2016). Antioxidant activities and oxidative stress inhibitory effects of ethanol extracts from Cornus officinalis on raw 264.7 cells. BMC Complement. Altern. Med. 16, 196. doi:10.1186/s12906-016-1172-3
Ju, C. G., Zhu, L., Wang, W., Gao, H., Xu, Y. B., and Jia, T. Z. (2022). Cornus officinalis prior and post-processing: Regulatory effects on intestinal flora of diabetic nephropathy rats. Front. Pharmacol. 13, 1039711. doi:10.3389/fphar.2022.1039711
Kao, M. P., Ang, D. S., Pall, A., and Struthers, A. D. (2010). Oxidative stress in renal dysfunction: Mechanisms, clinical sequelae and therapeutic options. J. Hum. Hypertens. 24 (1), 1–8. doi:10.1038/jhh.2009.70
Kitada, M., Ogura, Y., Suzuki, T., Sen, S., Lee, S. M., Kanasaki, K., et al. (2016). A very-low-protein diet ameliorates advanced diabetic nephropathy through autophagy induction by suppression of the mTORC1 pathway in Wistar fatty rats, an animal model of type 2 diabetes and obesity. Diabetologia 59 (6), 1307–1317. doi:10.1007/s00125-016-3925-4
Li, C., Ma, W. J., and Wang, W. H. (2015). Effect and mechanism of cornus officinalis on diabetes nephropathy in rats by inhibiting oxidative stress. J. Pract. Diabetology 11 (04), 41–43.
Liu, C. Y., Yang, S. H., Zhu, W., Zeng, H., Wei, K., and Tang, Q. (2019). Effect of Jinkui kidney decoction on podocyte apoptosis signaling in mice with diabetic nephropathy. Chin. Pharmacol. Bull. 35 (10), 1466–1470.
Liu, H., Xu, H. Q., Shen, C. S., and Wu, C. (2012). Effect of the best compatibility of components in Corni Fructus on WT1 expression in glomerular podocytes of type 2 diabetic rats with early nephropathy. Am. J. Chin. Med. 40 (3), 537–549. doi:10.1142/S0192415X12500413
Liu, W., Zhu, J. J., Xu, Z. M., Jiang, Z. Z., Lou, F. C., and Wang, T. (2016). Study on the therapeutic effect of total terpenes of cornus officinalis on KKay diabetes mice. Drug Eval. Res. 39 (06), 947–952. doi:10.7501/j.issn.1674-6376.2016.06.006
Lou, F. J., Zhang, N., and Bu, T. J. (2021). Study on the mechanism of cornus officinalis in the treatment of diabetes kidney disease. J. Clin. Nephrol. 21 (10), 819–825.
Malodobra-Mazur, M., Cierzniak, A., Kaliszewski, K., and Dobosz, T. (2021). PPARG hypermethylation as the first epigenetic modification in newly onset insulin resistance in human adipocytes. Genes 12 (6), 889. doi:10.3390/genes12060889
Malodobra-Mazur, M., Cierzniak, A., Ryba, M., Sozanski, T., Piorecki, N., and Kucharska, A. Z. (2022). Cornus mas L. Increases glucose uptake and the expression of PPARG in insulin-resistant adipocytes. Nutrients 14 (11), 2307. doi:10.3390/nu14112307
Najjar, R. S., Akhavan, N. S., Pourafshar, S., Arjmandi, B. H., and Feresin, R. G. (2021). Cornus officinalis var. koreana Kitam polyphenol extract decreases pro-inflammatory markers in lipopolysaccharide (LPS)-induced RAW 264.7 macrophages by reducing Akt phosphorylation. J. Ethnopharmacol. 270, 113734. doi:10.1016/j.jep.2020.113734
Park, C. H., Tanaka, T., and Yokozawa, T. (2013). Anti-diabetic action of 7-O-galloyl-D-sedoheptulose, a polyphenol from Corni Fructus, through ameliorating inflammation and inflammation-related oxidative stress in the pancreas of type 2 diabetics. Biol. Pharm. Bull. 36 (5), 723–732. doi:10.1248/bpb.b12-00543
Qi, M. Y., Xie, G. Y., Chen, K., Su, Y. H., Yu, S. Q., and Liu, H. R. (2014). Total triterpene acids, isolated from Corni Fructus, ameliorate progression of renal damage in streptozotocin-induced diabetic rats. Chin. J. Integr. Med. 20 (6), 456–461. doi:10.1007/s11655-013-1532-5
Qian, D. S., Zhu, Y. F., and Zhu, Q. (2001). Experimental study on the effect of ethanol extract from Cornus officinalis on the expression of GLUT4 in skeletal muscle of NIDDM rats. China J. Chin. Materia Medica 26 (12), 859–862. doi:10.3321/j.issn:1001-5302.2001.12.023
Samsu, N. (2021). Diabetic nephropathy: Challenges in pathogenesis, diagnosis, and treatment. Biomed. Res. Int. 2021, 1497449. doi:10.1155/2021/1497449
Sharp-Tawfik, A. E., Coiner, A. M., Marelia, C. B., Kazantzis, M., Zhang, C., and Burkhardt, B. R. (2019). Compositional analysis and biological characterization of Cornus officinalis on human 1.1B4 pancreatic beta cells. Mol. Cell. Endocrinol. 494 (20), 110491. doi:10.1016/j.mce.2019.110491
Sharp-Tawfik, A., Fletcher, J. D., Guergues, J., Marelia-Bennett, C., Wolf, T. J., Coiner, A. M., et al. (2022). Proteomic examination of Cornus officinalis stimulated 1.1B4 human pancreatic cells reveals activation of autophagy and Keap1/Nrf2 pathway. Mol. Cell. Endocrinol. 557, 111773. doi:10.1016/j.mce.2022.111773
Tavafi, M. (2013). Diabetic nephropathy and antioxidants. J. Nephropathol. 2 (1), 20–27. doi:10.5812/nephropathol.9093
Wang, M. R., Yu, L. H., Wang, T. T., Wang, Y. M., and Han, M. X. (2018). Effects of Dihuang decoction on serum inflammatory factors, renal function and microcirculation in patients with early diabetic nephropathy with qiyin deficiency. China J. Chin. Materia Medica 43 (06), 1276–1281. doi:10.19540/j.cnki.cjcmm.2018.0050
Wen, Y. M., Dong, X. L., and Li, P. (2015). Data mining study on diabetic nephropathy symptoms and medication rules. China J. Traditional Chin. Med. 30 (10), 3665–3670. doi:10.16588/j.cnki.issn1002-1108.2018.03.003
Wong, C. K., Ho, A. W., Tong, P. C., Yeung, C. Y., Kong, A. P., Lun, S. W. M., et al. (2007). Aberrant activation profile of cytokines and mitogen-activated protein kinases in type 2 diabetic patients with nephropathy. Clin. Exp. Immunol. 149 (1), 123–131. doi:10.1111/j.1365-2249.2007.03389.x
Wu, J. N. (2012). Study on the hypoglycemic effect of commonly used single traditional Chinese medicine in clinical practice. Jilin J. Chin. Med. 32 (02), 158–161. doi:10.13463/j.cnki.jlzyy.2012.02.035
Xue, R., Gui, D., Zheng, L., Zhai, R., Wang, F., and Wang, N. (2017). Mechanistic insight and management of diabetic nephropathy: Recent progress and future perspective. J. Diabetes Res. 2017, 1839809. doi:10.1155/2017/1839809
Yamabe, N., Kang, K. S., Goto, E., Tanaka, T., and Yokozawa, T. (2007a). Beneficial effect of Corni Fructus, a constituent of Hachimi-jio-gan, on advanced glycation end-product-mediated renal injury in Streptozotocin-treated diabetic rats. Biol. Pharm. Bull. 30 (3), 520–526. doi:10.1248/bpb.30.520
Yamabe, N., Kang, K. S., Matsuo, Y., Tanaka, T., and Yokozawa, T. (2007b). Identification of antidiabetic effect of iridoid glycosides and low molecular weight polyphenol fractions of Corni Fructus, a constituent of Hachimi-jio-gan, in streptozotocin-induced diabetic rats. Biol. Pharm. Bull. 30 (7), 1289–1296. doi:10.1248/bpb.30.1289
Yang, C. M., Cheng, W., Li, Y. Y., and Gao, J. D. (2022). Based on real-world data, we discussed the treatment of diabetic nephropathy by traditional Chinese medicine Study of medication rules. Mod. Traditional Chin. Med. Materia Medica-World Sci. Technol. 24 (10), 3949–3957. doi:10.11842/wst.20210905008
Zhang, Z. M., Yang, L., Wan, Y., Liu, C., Jiang, S., Shang, E. X., et al. (2021). Integrated gut microbiota and fecal metabolomics reveal the renoprotective effect of Rehmanniae Radix Preparata and Corni Fructus on adenine-induced CKD rats. J. Chromatogr. B 1174, 122728. doi:10.1016/j.jchromb.2021.122728
Keywords: diabetic nephropathy, Cornus officinalis, active compounds, Chinese herbal medicine, research progress
Citation: Wu C, Wang J, Zhang R, Zhao H, Li X, Wang L, Liu P and Li P (2023) Research progress on Cornus officinalis and its active compounds in the treatment of diabetic nephropathy. Front. Pharmacol. 14:1207777. doi: 10.3389/fphar.2023.1207777
Received: 18 April 2023; Accepted: 27 June 2023;
Published: 05 July 2023.
Edited by:
Chi Man Koon, The Chinese University of Hong Kong, Hong Kong SAR, ChinaReviewed by:
Dingkun Gui, Shanghai Jiao Tong University, ChinaDe Jin, Hangzhou Hospital of Traditional Chinese Medicine, China
Copyright © 2023 Wu, Wang, Zhang, Zhao, Li, Wang, Liu and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Lifan Wang, wlf4648374@163.com; Peng Liu, drliupeng@sina.cn; Ping Li, lp8675@163.com